Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy

Total article views   HTML views PDF downloads Totals
11,551 Dovepress* 7,996+ 1,654 9,650
PubMed Central* 3,555 498 4,053
Totals 11,551 2,152 13,703
*Since 11 April 2019

View citations on PubMed Central and Google Scholar